LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 308

Search options

  1. Article ; Online: Adipose invasion of muscle in Wagyu cattle: Monitoring by histology and melting temperature.

    Valenzuela, J L / Lloyd, S S / Mastaglia, F L / Dawkins, R L

    Meat science

    2020  Volume 163, Page(s) 108063

    Abstract: Remarkably, Wagyu cattle progressively desaturate intramuscular and subcutaneous fat leading to melting temperatures (Tm) well below 38°C. In parallel, the adipose tissue expands, arborises and invades the muscle. The process is aggressive in that it ... ...

    Abstract Remarkably, Wagyu cattle progressively desaturate intramuscular and subcutaneous fat leading to melting temperatures (Tm) well below 38°C. In parallel, the adipose tissue expands, arborises and invades the muscle. The process is aggressive in that it leads to loss of myofibres resulting in much smaller fascicles and therefore fine marbling or snowflaking. The "Microscopic score" appears to be an excellent measure of marbling especially for lesser and greater degrees which are not quantified reliably by others methods. By comparing muscle groups, we conclude that the tailhead is a suitable site for sequential monitoring. Melting temperatures of intramuscular and subcutaneous tissue are also useful.
    MeSH term(s) Adipose Tissue/anatomy & histology ; Adipose Tissue/chemistry ; Animals ; Body Fat Distribution ; Cattle ; Muscle, Skeletal/anatomy & histology ; Muscle, Skeletal/metabolism ; Myofibrils ; Red Meat/analysis ; Transition Temperature
    Language English
    Publishing date 2020-01-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 753319-6
    ISSN 1873-4138 ; 0309-1740
    ISSN (online) 1873-4138
    ISSN 0309-1740
    DOI 10.1016/j.meatsci.2020.108063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

    Roberts, Bradley / Theunissen, Frances / Mastaglia, Francis L / Akkari, P Anthony / Flynn, Loren L

    International journal of molecular sciences

    2022  Volume 23, Issue 16

    Abstract: Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease classified as both a neurodegenerative and neuromuscular disorder. With a complex aetiology and no current cure for ALS, broadening the understanding of disease ... ...

    Abstract Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease classified as both a neurodegenerative and neuromuscular disorder. With a complex aetiology and no current cure for ALS, broadening the understanding of disease pathology and therapeutic avenues is required to progress with patient care. Alpha-synuclein (αSyn) is a hallmark for disease in neurodegenerative disorders, such as Parkinson's disease, Lewy body dementia, and multiple system atrophy. A growing body of evidence now suggests that αSyn may also play a pathological role in ALS, with αSyn-positive Lewy bodies co-aggregating alongside known ALS pathogenic proteins, such as
    MeSH term(s) Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/metabolism ; Amyotrophic Lateral Sclerosis/therapy ; Humans ; Lewy Bodies/metabolism ; Lewy Body Disease/pathology ; Multiple System Atrophy/pathology ; Synucleinopathies ; alpha-Synuclein/genetics ; alpha-Synuclein/metabolism
    Chemical Substances alpha-Synuclein
    Language English
    Publishing date 2022-08-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23169364
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset.

    Theunissen, Frances / Anderton, Ryan S / Mastaglia, Frank L / James, Ian / Bedlack, Richard / Akkari, P Anthony

    Scientific reports

    2022  Volume 12, Issue 1, Page(s) 14739

    Abstract: Neurofilament heavy (NEFH) is one of the critical proteins required for the formation of the neuronal cytoskeleton and polymorphisms in NEFH are reported as a rare cause of sporadic ALS (sALS). In the current study, a candidate tetranucleotide (TTTA) ... ...

    Abstract Neurofilament heavy (NEFH) is one of the critical proteins required for the formation of the neuronal cytoskeleton and polymorphisms in NEFH are reported as a rare cause of sporadic ALS (sALS). In the current study, a candidate tetranucleotide (TTTA) repeat variant in NEFH was selected using an in-silico short structural variant (SSV) evaluation algorithm and investigated in two cohorts of North American sALS patients, both separately and combined (Duke cohort n = 138, Coriell cohort n = 333; combined cohort n = 471), compared to a group of healthy controls from the Coriell Institute biobank (n = 496). Stratification according to site of disease onset revealed that the 9 TTTA allele was associated with reduced disease risk, specifically confined to spinal-onset sALS patients in the Duke cohort (p = 0.001). Furthermore, carriage of the 10 TTTA allele was associated with a 2.7 year later age of disease onset in the larger combined sALS cohort (p = 0.02). These results suggest that the 9 and 10 TTTA motif length may have a protective advantage for potentially lowering the risk of sALS and delaying the age of disease onset, however, these results need to be replicated in larger multicenter and multi-ethnic cohorts.
    MeSH term(s) Amyotrophic Lateral Sclerosis/epidemiology ; Amyotrophic Lateral Sclerosis/genetics ; Genetic Predisposition to Disease ; Humans ; Intermediate Filaments ; Mutation ; Neurofilament Proteins/genetics ; Polymorphism, Genetic
    Chemical Substances Neurofilament Proteins ; neurofilament protein H (108688-71-7)
    Language English
    Publishing date 2022-08-30
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-022-18942-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.

    Mastaglia, F L

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology

    2010  Volume 28, Issue 2, Page(s) 66–71

    Abstract: Sporadic inclusion body myositis (sIBM) is the most common myopathy presenting over the age of 40 years but its prevalence varies considerably in different populations. Genetic factors play a part in the pathogenesis of sIBM and in Caucasians ... ...

    Abstract Sporadic inclusion body myositis (sIBM) is the most common myopathy presenting over the age of 40 years but its prevalence varies considerably in different populations. Genetic factors play a part in the pathogenesis of sIBM and in Caucasians susceptibility has been linked to the HLA-DR3 allele and the 8.1 MHC ancestral haplotype (AH) which is also associated with other autoimmune diseases. The variable prevalence of sIBM in different populations may be related to differences in the population frequency of this haplotype. Our recent observations indicate that the clinical phenotype at presentation is also quite variable and that the influence of the MHC is more complex than previously appreciated with HLA alleles also having modifying effects on the age-at-onset, severity and rate of progression of the disease. Recent recombinant mapping studies of polymorphisms in the Class II/III regions of the MHC by our group have further refined the susceptibility region and have identified a number of candidate genes warranting further investigation. The significance of these findings for the pathogenesis of the disease is discussed.
    MeSH term(s) Age of Onset ; Disease Progression ; Disease Susceptibility ; Genetics, Population ; Haplotypes ; Humans ; Major Histocompatibility Complex/genetics ; Muscle, Skeletal/pathology ; Myositis, Inclusion Body/epidemiology ; Myositis, Inclusion Body/genetics ; Myositis, Inclusion Body/pathology ; Pedigree ; Phenotype ; Prevalence
    Language English
    Publishing date 2010-02-01
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 2102328-1
    ISSN 1128-2460
    ISSN 1128-2460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: What to do ... When the treatment does not work: polymyositis.

    Mastaglia, F L

    Postgraduate medical journal

    2008  Volume 84, Issue 993, Page(s) 382–384

    MeSH term(s) Diagnosis, Differential ; Drug Resistance ; Humans ; Myositis, Inclusion Body/diagnosis ; Myositis, Inclusion Body/drug therapy ; Polymyositis/diagnosis ; Polymyositis/drug therapy ; Recurrence ; Treatment Failure
    Language English
    Publishing date 2008-07
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/jnnp.2007.142562
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: When the treatment does not work: polymyositis.

    Mastaglia, F L

    Practical neurology

    2008  Volume 8, Issue 3, Page(s) 170–174

    MeSH term(s) Aged ; Dysferlin ; Female ; Humans ; Inclusion Bodies/pathology ; Male ; Membrane Proteins/deficiency ; Middle Aged ; Muscle Proteins/deficiency ; Polymyositis/etiology ; Polymyositis/pathology ; Polymyositis/therapy
    Chemical Substances DYSF protein, human ; Dysferlin ; Membrane Proteins ; Muscle Proteins
    Language English
    Publishing date 2008-06
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 2170881-2
    ISSN 1474-7766 ; 1474-7758
    ISSN (online) 1474-7766
    ISSN 1474-7758
    DOI 10.1136/jnnp.2007.142562
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Statin myotoxicity: a review of genetic susceptibility factors.

    Needham, M / Mastaglia, F L

    Neuromuscular disorders : NMD

    2014  Volume 24, Issue 1, Page(s) 4–15

    Abstract: The 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors (statins) are among the most common medications prescribed worldwide, but their efficacy and toxicity vary between individuals. One of the major factors contributing to intolerance ... ...

    Abstract The 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors (statins) are among the most common medications prescribed worldwide, but their efficacy and toxicity vary between individuals. One of the major factors contributing to intolerance and non-compliance are the muscle side-effects, which range from mild myalgia through to severe life-threatening rhabdomyolysis. One way to address this is pharmacogenomic screening, which aims to individualize therapy to maximize efficacy whilst avoiding toxicity. Genes encoding proteins involved in the metabolism of statins as well as genes known to cause inherited muscle disorders have been investigated. To-date only polymorphisms in the SLCO1B1 gene, which encodes the protein responsible for hepatic uptake of statins, and the COQ2 gene, important in the synthesis of coenzyme Q10, have been validated as being strongly associated with statin-induced myopathy. The aim of this review is to summarize studies investigating genetic factors predisposing to statin myopathy and myalgia, as the first step towards pharmacogenomic screening to identify at risk individuals.
    MeSH term(s) Genetic Predisposition to Disease ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Muscular Diseases/chemically induced ; Muscular Diseases/genetics ; Pharmacogenetics ; Risk Factors
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2014-01
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1077681-3
    ISSN 1873-2364 ; 0960-8966
    ISSN (online) 1873-2364
    ISSN 0960-8966
    DOI 10.1016/j.nmd.2013.09.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

    Moran, E M / Mastaglia, F L

    Clinical and experimental immunology

    2014  Volume 178, Issue 3, Page(s) 405–415

    Abstract: The idiopathic inflammatory myopathies are a heterogeneous group of disorders characterised by diffuse muscle weakness and inflammation. A common immunopathogenic mechanism is the cytokine-driven infiltration of immune cells into the muscle tissue. ... ...

    Abstract The idiopathic inflammatory myopathies are a heterogeneous group of disorders characterised by diffuse muscle weakness and inflammation. A common immunopathogenic mechanism is the cytokine-driven infiltration of immune cells into the muscle tissue. Recent studies have further dissected the inflammatory cell types and associated cytokines involved in the immune-mediated myopathies and other chronic inflammatory and autoimmune disorders. In this review we outline the current knowledge of cytokine expression profiles and cellular sources in the major forms of inflammatory myopathy and detail the known mechanistic functions of these cytokines in the context of inflammatory myositis. Furthermore, we discuss how the application of this knowledge may lead to new therapeutic strategies for the treatment of the inflammatory myopathies, in particular for cases resistant to conventional forms of therapy.
    MeSH term(s) Animals ; Autoantibodies/immunology ; Cytokines/physiology ; Dermatomyositis/immunology ; Humans ; Myositis/drug therapy ; Myositis/etiology ; Myositis/immunology ; Polymyositis/immunology ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
    Chemical Substances Autoantibodies ; Cytokines ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2014-09-15
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1111/cei.12445
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Inflammatory muscle diseases.

    Mastaglia, F L

    Neurology India

    2008  Volume 56, Issue 3, Page(s) 263–270

    Abstract: The three major immune-mediated inflammatory myopathies, dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM), each have their own distinctive clinical features, underlying pathogenetic mechanisms and patterns of muscle gene ... ...

    Abstract The three major immune-mediated inflammatory myopathies, dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM), each have their own distinctive clinical features, underlying pathogenetic mechanisms and patterns of muscle gene expression. In DM a complement-dependent humoral process thought to be initiated by antibodies to endothelial cells results in a microangiopathy with secondary ischemic changes in muscles. On the other hand, in PM and IBM there is a T-cell response with invasion of muscle fibers by CD8+ lymphocytes and perforin-mediated cytotoxic necrosis. In IBM degenerative changes are also a feature and comprise autophagia with rimmed vacuole formation and inclusions containing beta-amyloid and other proteins whose accumulation may be linked to impaired proteasomal function. The relationship between the inflammatory and degenerative component remains unclear, as does the basis for the selective vulnerability of certain muscles and the resistance to conventional forms of immunotherapy in most cases of IBM. Patients with DM or PM usually respond to treatment with glucocorticoids and immunosuppressive agents but their use remains largely empirical. Intravenous immunoglobulin therapy can be used to achieve disease control in patients with severe weakness or dysphagia, or in patients with immunodeficiency, but its use is limited by expense. Emerging therapies for resistant cases include TNFalpha inhibitors (etanercept, infliximab) and monoclonal antibodies (rituximab, alemtuzumab). However, experience with these therapies is still limited and there is a need for randomized trials to test their efficacy and establish guidelines for their use in clinical practice.
    MeSH term(s) Animals ; Dermatomyositis/immunology ; Dermatomyositis/pathology ; Dermatomyositis/therapy ; Humans ; Myositis/classification ; Myositis/immunology ; Myositis/pathology ; Myositis/therapy ; Myositis, Inclusion Body/immunology ; Myositis, Inclusion Body/pathology ; Myositis, Inclusion Body/therapy ; Polymyositis/immunology ; Polymyositis/pathology ; Polymyositis/therapy
    Language English
    Publishing date 2008-10-28
    Publishing country India
    Document type Journal Article ; Review
    ZDB-ID 415522-1
    ISSN 1998-4022 ; 0028-3886
    ISSN (online) 1998-4022
    ISSN 0028-3886
    DOI 10.4103/0028-3886.43444
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Adipose invasion of muscle in Wagyu cattle: Monitoring by histology and melting temperature

    Valenzuela, J.L / Lloyd, S.S / Mastaglia, F.L / Dawkins, R.L

    Meat science. 2020 May, v. 163

    2020  

    Abstract: Remarkably, Wagyu cattle progressively desaturate intramuscular and subcutaneous fat leading to melting temperatures (Tm) well below 38°C. In parallel, the adipose tissue expands, arborises and invades the muscle. The process is aggressive in that it ... ...

    Abstract Remarkably, Wagyu cattle progressively desaturate intramuscular and subcutaneous fat leading to melting temperatures (Tm) well below 38°C. In parallel, the adipose tissue expands, arborises and invades the muscle. The process is aggressive in that it leads to loss of myofibres resulting in much smaller fascicles and therefore fine marbling or snowflaking.The “Microscopic score” appears to be an excellent measure of marbling especially for lesser and greater degrees which are not quantified reliably by others methods.By comparing muscle groups, we conclude that the tailhead is a suitable site for sequential monitoring. Melting temperatures of intramuscular and subcutaneous tissue are also useful.
    Keywords Wagyu ; adipose tissue ; cattle ; histology ; marbling ; melting ; melting point ; monitoring ; muscles ; subcutaneous fat ; temperature
    Language English
    Dates of publication 2020-05
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 753319-6
    ISSN 1873-4138 ; 0309-1740
    ISSN (online) 1873-4138
    ISSN 0309-1740
    DOI 10.1016/j.meatsci.2020.108063
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top